Aligos Therapeutics (ALGS) Amortizatization of Intangibles (2019 - 2026)

Aligos Therapeutics (ALGS) has 8 years of Amortizatization of Intangibles data on file, last reported at $419000.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles rose 205.84% year-over-year to $419000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 34.53% YoY) and the FY2025 annual result came in at $2.2 million, up 22.71% from the prior year.
• Amortizatization of Intangibles declined to $419000.0 in Q1 2026, from $444000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $897000.0 in Q2 2025 to a low of -$9000.0 in Q1 2022.
• A 5-year average of $331533.3 and a median of $267000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2022 — Amortizatization of Intangibles soared 3550.0% — and 2024, when it sank 68.54%.
• Tracing ALGS's Amortizatization of Intangibles over 5 years: stood at $75000.0 in 2022, then soared by 109.33% to $157000.0 in 2023, then soared by 136.94% to $372000.0 in 2024, then climbed by 19.35% to $444000.0 in 2025, then retreated by 5.63% to $419000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $419000.0 (Q1 2026), $444000.0 (Q4 2025), and $710000.0 (Q3 2025), per Business Quant data.